Rockland Trust Co. Buys Shares of 10,669 Walgreens Boots Alliance Inc (NASDAQ:WBA)

Rockland Trust Co. bought a new stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 10,669 shares of the pharmacy operator’s stock, valued at approximately $561,000.

A number of other institutional investors have also recently bought and sold shares of WBA. NEXT Financial Group Inc increased its stake in Walgreens Boots Alliance by 27.8% during the second quarter. NEXT Financial Group Inc now owns 2,663 shares of the pharmacy operator’s stock worth $145,000 after acquiring an additional 580 shares during the last quarter. First National Bank of South Miami increased its stake in Walgreens Boots Alliance by 3.0% during the second quarter. First National Bank of South Miami now owns 10,386 shares of the pharmacy operator’s stock worth $566,000 after acquiring an additional 303 shares during the last quarter. Synovus Financial Corp increased its stake in Walgreens Boots Alliance by 3.6% during the second quarter. Synovus Financial Corp now owns 16,177 shares of the pharmacy operator’s stock worth $883,000 after acquiring an additional 555 shares during the last quarter. H D Vest Advisory Services acquired a new stake in Walgreens Boots Alliance during the second quarter worth about $236,000. Finally, Cornerstone Advisors Inc. increased its stake in Walgreens Boots Alliance by 131.6% during the second quarter. Cornerstone Advisors Inc. now owns 894 shares of the pharmacy operator’s stock worth $49,000 after acquiring an additional 508 shares during the last quarter. 59.69% of the stock is currently owned by institutional investors.

Shares of NASDAQ WBA opened at $53.99 on Friday. Walgreens Boots Alliance Inc has a fifty-two week low of $49.03 and a fifty-two week high of $86.31. The business has a 50 day moving average price of $53.09 and a two-hundred day moving average price of $53.67. The company has a quick ratio of 0.37, a current ratio of 0.76 and a debt-to-equity ratio of 0.49. The firm has a market cap of $47.03 billion, a PE ratio of 8.61, a price-to-earnings-growth ratio of 1.33 and a beta of 0.89.

In other Walgreens Boots Alliance news, CAO Marco Patrick Anthony Pagni sold 215,323 shares of the firm’s stock in a transaction that occurred on Wednesday, August 14th. The stock was sold at an average price of $50.48, for a total transaction of $10,869,505.04. Following the completion of the sale, the chief accounting officer now owns 357,851 shares in the company, valued at approximately $18,064,318.48. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. 15.73% of the stock is owned by company insiders.

A number of equities research analysts have recently issued reports on the company. JPMorgan Chase & Co. lowered their target price on Walgreens Boots Alliance from $74.00 to $73.00 and set an “overweight” rating for the company in a research note on Friday, June 28th. Deutsche Bank assumed coverage on Walgreens Boots Alliance in a research note on Thursday, September 12th. They issued a “sell” rating for the company. Cleveland Research reiterated a “hold” rating on shares of Walgreens Boots Alliance in a research note on Monday, September 9th. BidaskClub upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Wednesday, September 11th. Finally, ValuEngine upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Wednesday, October 2nd. Seven equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and three have given a buy rating to the company’s stock. Walgreens Boots Alliance has an average rating of “Hold” and a consensus target price of $62.24.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

See Also: What is a good rate of return for a mutual fund?

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.